Cooper Companies (NASDAQ:COO) Stock Bought by Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of The Cooper Companies, Inc. (NASDAQ:COO). In a filing disclosed on November 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in Cooper Companies stock on October 14th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 11/2/2026.
• Purchased $1,001 – $15,000 in shares of argenex (NASDAQ:ARGX) on 10/27/2026.
• Sold $1,001 – $15,000 in shares of Illumina (NASDAQ:ILMN) on 10/27/2026.
• Sold $1,001 – $15,000 in shares of Revvity (NYSE:RVTY) on 10/27/2026.
• Sold $15,001 – $50,000 in shares of PTC (NASDAQ:PTC) on 10/27/2026.
• Purchased $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 10/27/2026.
• Purchased $1,001 – $15,000 in shares of MACOM Technology Solutions (NASDAQ:MTSI) on 10/27/2026.
• Sold $1,001 – $15,000 in shares of Micron Solutions (OTCMKTS:MICR) on 10/21/2026.
• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/21/2026.
• Purchased $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 10/21/2026.

Cooper Companies Price Performance

Shares of NASDAQ:COO traded down $0.74 during midday trading on Thursday, hitting $62.19. 1,949,503 shares of the stock were exchanged, compared to its average volume of 2,719,852. The stock has a market cap of $11.83 billion, a P/E ratio of 21.23, a PEG ratio of 2.50 and a beta of 0.83. The company has a current ratio of 1.22, a quick ratio of 0.73 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a twelve month low of $51.01 and a twelve month high of $89.83. The company has a 50 day moving average price of $58.80 and a 200-day moving average price of $68.33.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Wednesday, September 9th. The medical device company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.12 by $0.03. Cooper Companies had a net margin of 13.46% and a return on equity of 10.90%. The business had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.10 billion. During the same period in the previous year, the firm earned $0.49 EPS. The business’s revenue for the quarter was up .5% compared to the same quarter last year. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. On average, research analysts forecast that The Cooper Companies, Inc. will post 4.53 earnings per share for the current year.

Cooper Companies declared that its Board of Directors has authorized a share repurchase plan on Wednesday, September 9th that permits the company to repurchase $3 billion in outstanding shares. This repurchase authorization permits the medical device company to buy up to 22.7% of its shares through open market purchases. Stock repurchase plans are typically an indication that the company’s board believes its shares are undervalued.

Institutional Trading of Cooper Companies

Several hedge funds and other institutional investors have recently bought and sold shares of COO. BlackRock Inc. purchased a new position in shares of Cooper Companies during the 2nd quarter worth $1,077,762,000. Generation Investment Management LLP purchased a new stake in Cooper Companies in the 2nd quarter valued at about $356,304,000. Jupiter Topco LLC purchased a new position in shares of Cooper Companies during the 2nd quarter worth about $305,074,000. JANA Partners Management LP lifted its holdings in shares of Cooper Companies by 0.5% during the 2nd quarter. JANA Partners Management LP now owns 3,582,480 shares of the medical device company’s stock worth $256,900,000 after acquiring an additional 17,322 shares during the period. Finally, Wellington Management Group LLP boosted its position in shares of Cooper Companies by 3.1% in the second quarter. Wellington Management Group LLP now owns 3,468,951 shares of the medical device company’s stock worth $248,758,000 after acquiring an additional 103,044 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on COO. Citigroup reaffirmed a “neutral” rating and issued a $60.00 target price (down from $80.00) on shares of Cooper Companies in a research note on Thursday, September 10th. Mizuho set a $75.00 price target on Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, September 10th. Robert W. Baird set a $61.00 price target on Cooper Companies and gave the stock a “neutral” rating in a report on Thursday, September 10th. JPMorgan Chase & Co. reduced their price objective on Cooper Companies from $71.00 to $58.00 and set a “neutral” rating on the stock in a research report on Thursday, September 10th. Finally, Bank of America lowered Cooper Companies from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $80.00 to $65.00 in a research note on Thursday, September 10th. Four research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $68.60.

Insider Activity at Cooper Companies

In other news, Director Paul A. Keel acquired 4,701 shares of the business’s stock in a transaction dated Friday, September 11th. The shares were bought at an average cost of $53.18 per share, for a total transaction of $249,999.18. Following the acquisition, the director directly owned 4,701 shares in the company, valued at $249,999.18. This trade represents a ∞ increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Lawrence Kurzius bought 10,000 shares of the firm’s stock in a transaction dated Wednesday, September 16th. The shares were purchased at an average price of $54.93 per share, with a total value of $549,300.00. Following the acquisition, the director directly owned 31,099 shares in the company, valued at approximately $1,708,268.07. This trade represents a 47.40% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders purchased 34,701 shares of company stock worth $1,880,039. 2.08% of the stock is owned by company insiders.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Cooper Companies

CooperCompanies is a global medical device company focused on vision care and women’s health. It serves customers in markets around the world through two primary businesses: CooperVision and CooperSurgical. CooperVision develops and sells contact lenses, including products for daily wear, astigmatism, presbyopia and myopia management. Its offerings include lenses made from silicone hydrogel and other materials, as well as specialty lens options. CooperSurgical provides products and services for women’s health and fertility care.